Black-hole system: in vivo continuous bioligand-assisted elimination of circulating tumor cells to prevent cancer recurrence and metastasis
Authors:
Open Access
- 2 November 2026
- journal article
- research article
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 12 (1) , 355
Abstract
In vivo continuous eradication of circulating tumor cells (CTCs) following chemotherapy represents a promising strategy to prevent cancer recurrence and metastasis, but remains a practical challenge. Here, we propose a bioligand-assisted in vivo therapy for dynamic check and hemo clearance of CTCs, termed the “Black-hole” system. Inspired by hemopurification, the Black-hole system integrates a peristaltic pump to maintain continuous blood flow, a functionalized microfluidic reservoir for CTCs sustained capture, and flexible tubing with needles for in vivo blood withdrawal and reinfusion. In this system, blood is drawn from the left carotid artery, passes through the microfluidic reservoir to selectively withhold CTCs, and is subsequently reinfused into the right jugular vein. Demonstration in a live tumor-bearing mouse model demonstrated the biosafety and efficacy of the system for single-pass, in vivo CTCs elimination. No significant morphological alterations were observed in major organs after the Black-hole system therapy. Notably, mice receiving the Black-hole therapy following paclitaxel chemotherapy exhibited a 50% survival rate, along with a 16.7% reduction in overall tumor recurrence. We expect the Black-hole system to become a safe and effective adjuvant therapy for postoperative cancer management.Keywords
Funding Information
- Shanghai Jiao Tong University (YG2019ZDA20, YG2021ZD19, YG2024ZD10)
- Science and Technology Commission of Shanghai Municipality (23YF1425600, 22Z510202478)
- E-Institutes of Shanghai Municipal Education Commission (21SG10, ZXWH1082101)
- National Natural Science Foundation of China (82402581)
This publication has 36 references indexed in Scilit:
- Three-Dimensional Magnetic Chip with Extracorporeal Circulation for Circulating Tumor Cell In Vivo Detection and Tumor Growth InhibitionAnalytical Chemistry, 2023
- An Implantable Magnetic Vascular Scaffold for Circulating Tumor Cell Removal In VivoAdvanced Materials, 2022
- The membrane receptor CD44: novel insights into metabolismTrends in Endocrinology & Metabolism, 2022
- Rapid and efficient capturing of circulating tumor cells from breast cancer Patient's whole blood via the antibody functionalized microfluidic (AFM) chipBiosensors and Bioelectronics, 2022
- In Vivo Coinstantaneous Identification of Hepatocellular Carcinoma Circulating Tumor Cells by Dual-Targeting Magnetic-Fluorescent NanobeadsNano Letters, 2020
- In Vivo Enrichment and Elimination of Circulating Tumor Cells by Using a Black Phosphorus and Antibody Functionalized Intravenous CatheterAdvanced Science, 2020
- Flexible Three-Dimensional Net for Intravascular Fishing of Circulating Tumor CellsAnalytical Chemistry, 2020
- Magnetic Chip Based Extracorporeal Circulation: A New Tool for Circulating Tumor Cell in Vivo DetectionAnalytical Chemistry, 2019
- EMT Transition States during Tumor Progression and MetastasisTrends in Cell Biology, 2019
- 113P: Enumeration and molecular characterization of circulating tumor cells in lung cancer patients using the GILUPI CellCollectorJournal of Thoracic Oncology, 2016